Downregulation of APOBEC3G by xenotropic murine leukemia-virus related virus (XMRV) in prostate cancer cells

Virology Journal

Volumn 8, Issue , 2011, Pages

  Dey, Abhinav ^a   Mantri, Chinmay ^a   Pandhare Dash, Jui ^a   Liu, Bindong ^a   Pratap, Siddharth ^b   Dash, Chandravanu ^a  

^a Vanderbilt Meharry Center for AIDS Research ^*  (United States)

^b MEHARRY MEDICAL COLLEGE   (United States)

Author keywords

APOBEC3G; Prostate; Retrovirus; XMRV

Indexed keywords

APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 3; CYTIDINE DEAMINASE; HYDROLASE; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL; DOWN REGULATION; NONHUMAN; PROSTATE CANCER; PROSTATE EPITHELIUM; PROTEIN ANALYSIS; PROTEIN EXPRESSION; TARGET CELL; XENOTROPIC MULV RELATED VIRUS;

AMINO ACID SEQUENCE; ANIMALS; BLOTTING, WESTERN; CELL LINE, TUMOR; CYTIDINE DEAMINASE; DOWN-REGULATION; ELECTROPHORESIS, POLYACRYLAMIDE GEL; EPITHELIAL CELLS; GENE EXPRESSION; HOST-PATHOGEN INTERACTIONS; HUMANS; MALE; MASS SPECTROMETRY; MICE; MOLECULAR SEQUENCE DATA; PROSTATE; PROSTATIC NEOPLASMS; VIRUS REPLICATION; XENOTROPIC MURINE LEUKEMIA VIRUS-RELATED VIRUS;

GAMMARETROVIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; XENOTROPIC MURINE LEUKEMIA VIRUS;

EID: 83155185457     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-8-531     Document Type: Article

References (25)

1. Identification of a novel gammaretrovirus in prostate tumors of patients homozygous for R462Q RNASEL variant. Urisman A, Molinaro RJ, Fischer N, Plummer SJ, Casey G, Klein EA, Malathi K, Tubbs RR, Ganem D, Silverman RH, DeRisi JL, PLoSPathog 2006 2 25
2. XMRV infection in patients with prostatecancer: novel serologic assay and correlation with PCR andFISH. Arnold RS, Makarova NV, Osunkoya AO, Suppiah S, Scott TA, Johnson NA, Bhosle SM, Liotta D, Hunter E, Marshall FF, et al. Urology 2010 75 755 761 10.1016/j.urology.2010.01.038 20371060
3. An infectious retrovirus susceptible to an IFN antiviral pathway from human prostate tumors. Dong B, Kim S, Hong S, Das Gupta J, Malathi K, Klein EA, Ganem D, DeRisi JL, Chow SA, Silverman RH, ProcNatlAcadSci USA 2007 104 1655 60 10.1073/pnas.0610291104 (Pubitemid 46214646)
4. XMRV ispresent in malignant prostatic epithelium and is associated with prostate cancer, especially high-grade tumors. Schlaberg R, Choe DJ, Brown KR, Thaker HM, Singh IR, ProcNatlAcadSci USA 106 16351 16356
5. No difference in antibody titers against xenotropicMLV related virus in prostate cancer cases and cancer-freecontrols. Sabunciyan S, Mandelberg N, Rabkin CS, Yolken R, Viscidi R, Mol Cell Probes 2010 25 134 136
6. Prevalence of human gammaretrovirus XMRV in sporadic prostate cancer. Fischer N, Hellwinkel O, Schulz C, Chun FK, Huland H, Aepfelbacher M, Schlomm T, J ClinVirol 2008 43 277 83
7. Lack of evidence for xenotropic murine leukemia virus-related virus (XMRV) in German prostate cancer patients. Hohn O, Krause H, Barbarotto P, Niederstadt L, Beimforde N, Miller K, Kurth R, Bannert N, Retrovirology 2009 6 92 10.1186/1742-4690-6-92 19835577
8. Prevalence of human xenotropic murine leukemia virus-related gammaretrovirus (XMRV) in Dutch prostate cancer patients. Verhaegh GW, de Jong AS, Smit FP, et al. Prostate 2010 71 415 20 20878949
9. XMRV: a new virus in prostate cancer? Aloia AL, Sfanos KS, Isaacs WB, et al. Cancer Res 2010 70 10028 33 10.1158/0008-5472.CAN-10-2837 20966126
10. Recombinant Origin of the Retrovirus XMRV. Paprotka T, Delviks-Frankenberry KA, Cingöz O, Martinez A, Kung H-J, Tepper CG, Hu W-S, Fivash MJ Jr, Coffin MJ, Pathak VK, Science 2011 31 May 2011/Page 1/10.1126/science.1205292
11. Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein. Sheehy AM, Gaddis NC, Choi JD, Malim MH, Nature 2002 418 646 650 10.1038/nature00939 12167863
12. Role of vif in replication of human immunodeficiencyvirus type 1 in CD4 T lymphocytes. Gabuzda DH, et al. J Virol 1992 66 6489 6495 1357189
13. Human APOBEC3proteins can inhibit xenotropic murine leukemia virus-related virus infectivity. Bogerd HP, Zhang FDBP, Cullen BR, Virology 2011 410 234 239 10.1016/j.virol.2010.11.011 21131013
14. Susceptibility of xenotropic murine leukemia virus-related virus (XMRV) to retroviral restriction factors. Groom HC, Yap MW, Galao RP, Neil SJ, Bishop KN, Proc Natl Acad Sci USA 2010 107 5166 5171 10.1073/pnas.0913650107 20194752
15. Inhibition of xenotropic murine leukemia virusrelated virus by APOBEC3 proteins and antiviral drugs. Paprotka T, et al. J Virol 2010 84 5719 5729 10.1128/JVI.00134-10 20335265
16. Apobec 3 G efficiently reduces infectivity of the human exogenousgammaretrovirus XMRV. Stieler K, Fischer N, PLoS One 2010 5 11738 10.1371/journal.pone.0011738 20668529
17. Inhibition of xenotropic murine leukemia virusrelatedvirus by APOBEC3 proteins in PBMCS. Paprotka T, et al. J Virol 2011 85 4888 4897 10.1128/JVI.00046-11 21325415
18. Xenotropic murine leukemia virus-related virus establishes an efficient spreading infection and exhibits enhanced transcriptional activity in prostate carcinoma cells. Rodriguez JJ, Goff SP, J Virol 2010 84 5 2556 62 10.1128/JVI.01969-09 20015990
19. Multiple integrated copies and high-level production of the human retrovirus XMRV from 22Rv1 prostate carcinoma cells. Knouf EC, et al. J Virol 2009 83 7353 7356 10.1128/JVI.00546-09 19403664
20. Resistance of human T cell leukemia virus type 1 to APOBEC3G restriction is mediated by elements in nucleocapsid. Derse D, Hill SA, Princler G, Lloyd P, Heidecker G, Proc Natl Acad Sci USA 2007 104 2915 2920 10.1073/pnas.0609444104 17299050 (Pubitemid 46327978)
21. Differential sensitivity of murine leukemia virus to APOBEC3-mediated inhibition is governed by virion exclusion. Doehle BP, Schafer A, Wiegand HL, Bogerd HP, Cullen BR, J Virol 2005 79 8201 8207 10.1128/JVI.79.13.8201-8207.2005 15956565 (Pubitemid 40853523)
22. Murine retrovirus escapes from murine APOBEC3 via two distinct novel mechanisms. Abudu A, Takaori-Kondo A, Izumi T, Shirakawa K, Kobayashi M, et al. Curr Biol 2006 16 1565 1570 10.1016/j.cub.2006.06.055 16890533 (Pubitemid 44142982)
23. APOBEC3G Genetic Variants and Their Influence on the Progression to AIDS. An P, Bleiber G, Duggal P, Nelson G, May M, Mangeat B, Alobwede I, Trono D, Vlahov D, Donfield S, Goedert JJ, Phair J, Buchbinder S, O'Brien SJ, Telenti A, Winkler CA, J Virol 2004 78 11070 11076 10.1128/JVI.78.20.11070-11076.2004 15452227 (Pubitemid 39299647)
24. + T cells. Chiu Y, Soros VB, Kreisberg J, Stopak K, Yonemoto Wes, Greene WC, Nature 2005 435 108 114 10.1038/nature03493 15829920 (Pubitemid 40655917)
25. Characterization of restrictions to human immunodeficiency virus type 1 infection of monocytes. Triques K, Stevenson M, J Virol 2004 78 5523 5527 10.1128/JVI.78.10.5523-5527.2004 15113933 (Pubitemid 38581504)